On December 7, 2021 Privo Technologies, Inc. ("Privo"), a biopharmaceutical company focused on optimizing state-of-the-art chemotherapies to be "Tough on cancer, Easy on patients", reported that the Company will be attending the virtual Biotech Showcase from January 17 to January 19, 2022 (Press release, Privo Technologies, DEC 7, 2021, View Source;utm_medium=rss&utm_campaign=privo-technologies-inc-to-attend-biotech-showcase-2022 [SID1234596547]). Members of Privo’s management team will be available for 1×1 meetings with interested parties. Those registered for the event can request a meeting with Privo through the partneringOne portal.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!